Zinc oxide Topical Product
RxNorm 1163041

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1163041 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: zinc oxide Topical Product.

The following semantic concepts and normalized strings are associated with this clinical entity:

FN
Product containing zinc oxide in cutaneous dose form (medicinal product form)
AUI:12903910
SCDG
Zinc oxide Topical Product
AUI:12292037
PT
Zinc oxide-containing product in cutaneous dose form
AUI:12904306

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

FNPrescribable

Full form of descriptor (FN):
Product containing zinc oxide in cutaneous dose form (medicinal product form)
(Atom ID: 12903910)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Product containing zinc oxide in cutaneous dose form (medicinal product form)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1163041
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12903910
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
FN
Full form of descriptor ()
Source Code
1303384008
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.

SCDGPrescribable

Semantic Clinical Dose Form Group (SCDG):
Zinc oxide Topical Product
(Atom ID: 12292037)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
zinc oxide Topical Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1163041
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12292037
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCDG
Semantic Clinical Dose Form Group (Ingredient + Dose Form Group)
Source Code
1163041
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
0.018 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.01 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.038 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0938 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.128 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.12 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.134 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.13 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.14 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.15 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.16 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.18 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.25 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.2 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.3 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.4 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
100 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
113 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
120 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
130 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
140 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
149 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
150 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
153 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
18 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
200 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
205 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
210 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
220 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
240 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
250 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
300 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
306 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
38 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
400 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
50 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
99 MG/ML
Available drug strengths listed in the order of ingredients from the drug

PTPrescribable

Designated preferred name (PT):
Zinc oxide-containing product in cutaneous dose form
(Atom ID: 12904306)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Zinc oxide-containing product in cutaneous dose form
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1163041
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12904306
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PT
Designated preferred name ()
Source Code
1303384008
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.